Literature DB >> 25735432

A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus.

Satoshi Hiramine1,2, Masaya Sugiyama1, Norihiro Furusyo2, Hirofumi Uto3, Akio Ido3, Hirohito Tsubouchi3, Hisayoshi Watanabe4, Yoshiyuki Ueno4, Masaaki Korenaga1, Kazumoto Murata1, Naohiko Masaki1, Jun Hayashi2, David L Thomas5, Masashi Mizokami6.   

Abstract

BACKGROUND: Genome-wide association studies have revealed several single-nucleotide polymorphisms around interleukin 28B (IL28B) that are strongly associated with hepatitis C virus (HCV) clearance. However, their predictive value is not perfect, which suggests that other genetic factors may also be involved in HCV clearance. We previously reported a wide variation in the length of a thymine-adenine (TA) dinucleotide repeat in the promoter region of IL28B and that the transcriptional activity of the promoter increased gradually in a TA repeat length-dependent manner.
METHODS: We determined the length of the TA repeats of 1,060 Japanese and 201 African-American samples to investigate the relation to spontaneous HCV clearance.
RESULTS: The distribution of the TA repeats greatly differed between the two ethnicities. The variation ranged from 10 to 18 repeats, and the most frequent allele, 12, accounted for over 80% for Japanese. The African-American data showed a gently sloping distribution, and the allele with six repeats was detected only in the African-American sample. The TA repeats 11 or greater were correlated with spontaneous clearance. Multiple logistic regression analysis extracted the genotype of the TA repeats as an independent factor in both the Japanese [p = 0.0004, odds ratio (OR) = 13.02 95% confidence interval (CI) = 2.59-237.0] and African-American (p = 0.027, OR = 3.70 95% CI = 1.16-11.8) populations.
CONCLUSIONS: A long TA repeat in the promoter region of IL28B was associated with spontaneous HCV clearance. Although its efficacy may be limited in Japanese population because of its allele distribution, this novel genetic factor will be useful for predicting HCV clearance especially for the African Americans.

Entities:  

Keywords:  Genetic marker; Interferon lambda 3; Microsatellite

Mesh:

Substances:

Year:  2015        PMID: 25735432      PMCID: PMC4651429          DOI: 10.1007/s00535-015-1056-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  31 in total

1.  Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.

Authors:  Tim O Lankisch; Christoph Schulz; Thomas Zwingers; Thomas J Erichsen; Michael P Manns; Volker Heinemann; Christian P Strassburg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

2.  Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan.

Authors:  Hirofumi Uto; Katsuhiro Hayashi; Kazunori Kusumoto; Satoru Hasuike; Kenji Nagata; Mayumi Kodama; Akio Ido; Michinori Kohara; Sherri O Stuver; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2005-12-19       Impact factor: 4.288

3.  Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes.

Authors:  V Lyamichev; A L Mast; J G Hall; J R Prudent; M W Kaiser; T Takova; R W Kwiatkowski; T J Sander; M de Arruda; D A Arco; B P Neri; M A Brow
Journal:  Nat Biotechnol       Date:  1999-03       Impact factor: 54.908

4.  Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.

Authors:  Y Kishihara; N Furusyo; K Kashiwagi; A Mitsutake; S Kashiwagi; J Hayashi
Journal:  J Infect Dis       Date:  2001-09-21       Impact factor: 5.226

5.  Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.

Authors:  J Borlak; T Thum; O Landt; K Erb; R Hermann
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations.

Authors:  Laura J Horsfall; David Zeitlyn; Ayele Tarekegn; Endashaw Bekele; Mark G Thomas; Neil Bradman; Dallas M Swallow
Journal:  Ann Hum Genet       Date:  2011-03       Impact factor: 1.670

8.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

9.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  4 in total

Review 1.  Host-virus interactions in hepatitis B and hepatitis C infection.

Authors:  Sachiyo Yoshio; Tatsuya Kanto
Journal:  J Gastroenterol       Date:  2016-02-19       Impact factor: 7.527

2.  Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.

Authors:  Vo Duy Thong; Rujipat Wasitthankasem; Pisit Tangkijvanich; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 3.  Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.

Authors:  S Chinnaswamy
Journal:  Genes Immun       Date:  2016-06-09       Impact factor: 2.676

4.  Functional genetic variants of the IFN-λ3 (IL28B) gene and transcription factor interactions on its promoter.

Authors:  Subhajit Roy; Debarati Guha Roy; Anand Bhushan; Seema Bharatiya; Sreedhar Chinnaswamy
Journal:  Cytokine       Date:  2021-03-13       Impact factor: 3.861

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.